Clinical Trial Update: Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 safety and feasibility trial of cell therapy for spinal cord injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Cell Therapy (unspecified)

Snippet

Sponsor: Translational Biosciences | Conditions: Spinal Cord Injury | Phase 1, Phase 2 | Status: WITHDRAWN